Administration, distribution, metabolism, excretion

The importance of administration, distribution, metabolism, excretion (AOME), and toxicology in drug development... 

The most important requirement that has to be met before Tc-radiopharmaceuticals can be used routinely in Nuclear Medicine is to have a registration file approved. For all radiopharmaceuticals, extensive information on the active ingredient (=the Tc-compound) is to be provided, including data on the exact chemical structure, the analytical methods to proof its purity and identity, the method to produce it from the precursor kit, batch data, etc. Another very important aspect of the registration file is the ADME (administration, distribution, metabolism, excretion) part, where especially the metabolic fate of the... 

Up to this point, the detection Unfit and sensitivity comparisons of the different sources have focused primarily on compoimds that ionize efficiently with all the techniques. It is important to understand the coverage or scope of an ionization technique across the chemical space of general interest, particularly when confronted with unknown compounds, or compounds whose structures are known but whose ionization properties have not been tested, and there is no time to assess a variety of options. This situation occurs in many drug discovery laboratories measuring in vitro ADME properties (administration, distribution, metabolism, excretion) where many different chemical species need to be assayed quickly. The data used to generate the relative efficiency values within a source in Tables 1-3 were used to calculate the relative MRM efficiency between the three sources and are shown in Table 13.4. The MALDI data were acquired in the most practical fashion to obtain a quantitative measurement where only a small percentage of the sample spot was ablated with a single raster. The ESI and APCI data were obtained by flow injection analysis at 200 and lOOOpL/min, respectively. Electrospray is the most sensitive ion source in nearly all... 

One of the factors that can alter the response to drugs is the concurrent administration of other drugs. There are several mechanisms by which drugs may interact, but most can be categorized as pharmacokinetic (absorption, distribution, metabolism, excretion), pharmacodynamic (additive or antagonistic effects), or combined interactions. The general principles of pharmacokinetics are discussed in Chapters 3 and 4 the general principles of pharmacodynamics in Chapter... 

Following oral administration to cattle, it is absorbed from the gastrointestinal tract, rapidly distributed, metabolized, excreted in the bile, and eliminated in the feces. Residues in liver averaged 0.4 ppm at 12 h after the last dose, whereas residues detected in other tissues were negligible (21). When radiolabeled monensin was administered to steers, essentially all radioactivity was eventually excreted in the feces after conversion to many metabolites that accumulated in the liver (22). 

An oral ADME (absorption, distribution, metabolism, excretion, following oral administration of the pesticide) study may also be of utility in refining the risk assessment. If a default value for dermal absorption of 100 % is applicable based on the physico-chemical properties of a substance and an appropriate oral ADME study is available, the results of this study may be used to refine the default value for dermal absorption. It is required that the oral absorption is determined at low dose levels in experimental animals, in order to obtain an accurate estimate of the oral absorption. Based on theoretical grounds and supported by a comparison of oral and dermal absorption data available for twelve pesticides, it is assumed that dermal absorption will not exceed oral absorption (Hakkert et al unpublished data). 

Furthermore, pharmacokinetic administration, distribution, metabolism and excretion (ADME) factors affect drug bioavailability, efficacy and safety, and, thus, are a vital consideration in the selection process of oral drug candidates in development pipelines. Since solubility, permeability, and the fraction of dose absorbed are fundamental BCS parameters that affect ADME, these BCS parameters should prove useful in drug discovery and development. In particular, the classification can used to make the development process more efficient.For example, in the case of a drug placed in BCS Class II where dissolution is the rate-limiting step to absorption, formulation principles such as polymorph selection, salt selection, complex formation, and particle size reduction (i.e., nanoparticles) could be applied earlier in development to improve bioavailability. 

Absorption, Distribution, Metabolism, Excretion. Examination of Section 2.6 clearly indicates that oral administration of NDMA has been the preferred route for studying its absorption, distribution, metabolism and excretion. This is not surprising since oral administration is easier to monitor when compared to other routes. The oral route seems to be the most pertinent to study since humans are most likely to be exposed to nitrosamines orally. Toxicokinetic data with regard to dermal and inhalation exposure of NDMA are clearly lacking. Furthermore, dermal and inhalation exposures may lead to different metabolic pathways and patterns of distribution and excretion, which could account for differences in the degree of toxicity exhibited by different routes of exposure. The metabolism of NDMA in isolated microsomal preparations seems to be well understood, but studies with cultured human cells could provide additional useful information. However, exploration of the denitrosation mechanism as an alternative to a-hydroxylation requires more attention. Determination of the urinary excretion of NDMA in control human volunteers and in individuals known to consume foods with high contents of nitrosamines could provide information concerning absorption and excretion of the xenobiotic. 

ADME (absorption, distribution, metabolism, excretion) trials. Animal species should be presented under each group by smallest (mouse) up to largest (monkey or other mammals). The route of administration should be presented under each species tested and the treatment group under each route of administration. For special toxicity trials, such as irritation and hemolysis trials, tabulate data as appropriate. An example of the format would be... 

Figure 41.6 Conceptual model of a druglike CORM. The number of CO ligands can be greater than 1 and the other ancillary ligands (L2-L6) can be the same or different. Distal substituents are just given as possible examples. ADME, administration, distribution, metabolism, and excretion PK, pharmacokinetics.

Although the antibacterial spectmm is similar for many of the sulfas, chemical modifications of the parent molecule have produced compounds with a variety of absorption, metaboHsm, tissue distribution, and excretion characteristics. Administration is typically oral or by injection. When absorbed, they tend to distribute widely in the body, be metabolized by the Hver, and excreted in the urine. Toxic reactions or untoward side effects have been characterized as blood dyscrasias crystal deposition in the kidneys, especially with insufficient urinary output and allergic sensitization. Selection of organisms resistant to the sulfonamides has been observed, but has not been correlated with cross-resistance to other antibiotic families (see Antibacterial AGENTS, synthetic-sulfonamides). 

Absorption, Distribution, Metabolism, and Excretion. There are no data available on the absorption, distribution, metabolism, or excretion of diisopropyl methylphosphonate in humans. Limited animal data suggest that diisopropyl methylphosphonate is absorbed following oral and dermal exposure. Fat tissues do not appear to concentrate diisopropyl methylphosphonate or its metabolites to any significant extent. Nearly complete metabolism of diisopropyl methylphosphonate can be inferred based on the identification and quantification of its urinary metabolites however, at high doses the metabolism of diisopropyl methylphosphonate appears to be saturated. Animal studies have indicated that the urine is the principal excretory route for removal of diisopropyl methylphosphonate after oral and dermal administration. Because in most of the animal toxicity studies administration of diisopropyl methylphosphonate is in food, a pharmacokinetic study with the compound in food would be especially useful. It could help determine if the metabolism of diisopropyl methylphosphonate becomes saturated when given in the diet and if the levels of saturation are similar to those that result in significant adverse effects. 

Thus, %F is defined as the area under the curve normalized for administered dose. Blood drug concentration is affected by the dynamics of dissolution, solubility, absorption, metabolism, distribution, and elimination. In addition to %F, other pharmacokinetic parameters are derived from the drug concentration versus time plots. These include the terms to describe the compound s absorption, distribution, metabolism and excretion, but they are dependent to some degree on the route of administration of the drug. For instance, if the drug is administered by the intravenous route it will undergo rapid distribution into the tissues, including those tissues that are responsible for its elimination. 

The answer is e. (Hardman, p 21J The fraction of a drug dose absorbed after oral administration is affected by a wide variety of factors that can strongly influence the peak blood levels and the time to peak blood concentration. The Vd and the total body clearance (Vd x first-order fte) also are important in determining the amount of drug that reaches the target tissue. Only the area under the blood concentration-time curve, however, reflects absorption, distribution, metabolism, and excretion factors it is the most reliable and popular method of evaluating bioavailability... 

Comparative Toxicokinetics. Based on the rat study by Albro and Moore (1974), di-n-octylphthalate appears to be readily absorbed following oral administration, metabolized extensively, and excreted primarily in the urine. Because of the lack of human data and limited animal data on the absorption, distribution, metabolism, and excretion of di-n-octylphthalate, additional studies are needed in order to make comparisons on the toxicokinetics across species. 

T. L. Morton, E. A. Murrill, J. M. Cannon, J. L. Skaptason, E. C. Bisinger, V. Reddy, R. N. Gatz, Absorption, Distribution, Metabolism and Excretion of 14C-Tributyl Phosphate in Sprague-Dawley Rats Following Dermal, Oral and Intravenous Administration , in Proceedings of the Fifth North American ISSX Meeting , Tucson, Arizona, USA, October 17-21, 1993, p. 196. 

With the exception of intravenous administration, where a drug is injected directly into the bloodstream, all the routes of administration require the drug to be absorbed before it can enter the bloodstream for distribution to target sites. Metabolism may precede distribution to the site of action, for example, in the case of oral administration. The human body also has a clearance process to eliminate drugs through excretion. We will now consider absorption, distribution, metabolism, and excretion with reference to Fig. 5.5. 

The pharmacokinetics of ibogaine have not been fully elucidated (Popik and Click 1996). Its absorption, distribution, metabolism, and excretion are not fully clear. The route of administration notably affects ibogaine s efficacy, with greater effects subcutaneously than intraperitoneally (Pearl et al. 1997). The half-life of ibogaine is approximately 1 hour in rodents, and it is not detectable in the brain after 12 hours, although the assays used may have lacked sensitivity (Dhahir 1971 Zetler et al. 1972 Popik and Click 1996). 

Absorption, distribution, metabolism and excretion (ADME) of the test substance after oral administration in one species, usually the rat, as well as dermal absorption in vitro (human and rat skin) or in vivo (rat)... 

Mechanism of Action A direct thrombin inhibitor that reversibly binds to thrombin-active sites. Inhibits thrombin-catalyzed or thrombin-induced reactions, including fibrin formation, activation of coagulant factors V, VIII, and XIII also inhibits protein C formation, and platelet aggregation. Therapeutic Effect Produces anticoagulation. Pharmacokinetics Following IV administration, distributed primarily in extracellular fluid. Protein binding 54%. Metabolized in the liver. Primarily excreted in the feces, presumably through biliary secretion. Half-life 39-51 min. 

Pharmacokinetics Plasma concentrations peak within 0.5 to 2.5 hr after ocular administration. Distributed into aqueous humor. Metabolized in liver. Primarily excreted in urine. Half-life 3 hr. 

Mechanism of Action A propylamine derivative antihistamine that competes with histamine for histamine receptor sites on cells in the blood vessels, gastrointestinal (GI) tract, and respiratory tract. TAerapfiMtic Effect Inhibits symptoms associated with seasonal allergic rhinitis such as increased mucus production and sneezing. Pharmacokinetics Well absorbed after PO and parenteral administration. Food delays absorption. Widely distributed. Metabolized in liver. Primarily excreted in urine. Not removed by dialysis. Half-life 20 hr. 

---